-
Hyderabad: Indian pharma industry is going through a lot of transformation and achieving scale. While export opportunities keep increasing, there is equal attention on strengthening the drug pipeline driven by research investments. Speaking at the CEO Conclave at BioAsia on Friday, Ajay Piramal, chairman, Piramal Group said, the company is increasing its investments onto more […]
-
Hyderabad: India is labelled as the preeminent pharmacy of the world, but the nation also should be known as the innovator of the world. When you want to create value, it starts with a patent and IP culture should be incentivised, and that’s why India should create a patent box regime, point out experts. A […]
-
Hyderabad: Indian pharma needs to move from low-risk research and innovation to high-risk research and innovation. And that’s where the country is lagging. Investing in high-risk innovation is very capital intensive and the return on that investment is both uncertain and long-term. To aid innovation, there needs to be adequate risk capital and a different […]
-
Hyderabad: The first day of the 19th edition of BioAsia witnessed a panel discussion with deliberations on the significance of partnerships between IT and Pharma companies to digitise healthcare and to venture into the new paradigm of delivering healthcare for better patient outcomes. Industry experts emphasised that data analytics will help the healthcare fraternity understand […]
-
Geoff Martha, CEO, Medtronic.
-
Hyderabad: Covid outbreak was an unprecedented situation and when Biological E was called to act upon it and develop a vaccine, the focus was on making the vaccine effective, safe, and affordable as health budgets were severely constrained in many countries. Speaking at a panel discussion on the first day of BioAsia titled ‘Two years […]
-
Hyderabad: When Bharat Biotech was looking at developing vaccines after the Covid outbreak, the highest priority was ensuring the safety in adult vaccination, Dr Krishna Ella, managing director, Bharat Biotech International noted on Thursday. Speaking at a panel session on the first day of BioAsia titled ‘Two years into the pandemic – Challenges, successes and […]
-
Hyderabad: Dr Drew Weissman, a globally renowned scientist in mRNA technology, said on Thursday that a pan-Coronavirus vaccine was being developed to ensure protection against all variants of the virus. “We want to create a vaccine that will stop any Coronavirus from infecting human beings. We are developing a few and they look promising,” he […]
-
Hyderabad: Government has been handholding the life sciences sector in boosting R&D, which is critical to the future. It is important to boost the pharma and medtech sectors. India has been a major importer of bulk drugs, but the nation needs to push the indigenous drug development. The government is pushing production-linked incentive scheme and […]
-
Hyderabad: In response to the Covid pandemic, while the scientific achievements have been absolutely outstanding such as vaccines in less than a year and a lot of progress on diagnostics, self-test kits and antivirals, technology, and the genomic surveillance, which has allowed to track the evolution of the virus, but global coordination and harmony was […]
-
Inaugurating the 19th edition of BioAsia, the annual flagship event of the life sciences industry, he said Covid has placed focus on the healthcare sector and there is a need for creating robust healthcare ecosystems.
-
Hyderabad: Interesting debates on various topics have been lined up for BioAsia, Asia’s largest life sciences and healthcare forum, that will be inaugurated by IT and Industries Minister KT Rama Rao on Thursday. Many experts and professionals from healthcare, pharmaceuticals, biopharma and medtech will participate in the forum. This year, the panelists will deliberate specifically […]
-
Hyderabad: Interesting debates on various topics have been lined up for BioAsia, Asia’s largest life sciences and healthcare forum, that will be inaugurated by IT and Industries Minister KT Rama Rao on Thursday. Many experts and professionals from healthcare, pharmaceuticals, biopharma and medtech will participate in the forum. This year, the panelists will deliberate specifically […]
-
The highlight of the 2022 edition will be a fireside chat between Industries and commerce minister K T Rama Rao and Bill Gates on a range of themes including the COVID-19 pandemic, learnings during the past two years.
-
Hyderabad: BioAsia, Asia’s largest life-sciences and healthcare forum, will be held virtually on February 24 and 25. This year, the 19th edition of the event, will deliberate on the pandemic, the learnings, progress made so far and also discuss on the future of healthcare to support and enable global collective recovery to pivot beyond the […]
-
Hyderabad: Federation of Asian Biotech Associations [FABA] has announced the recipients of this year’s awards. Dr B S Bajaj Memorial FABA Special Award-2022 will be conferred upon Mahima Datla, MD, Biological E for introducing Corbevax vaccine in augmenting the fight against Covid-19 and B P Acharya, patron, FABA has been selected for the FABA Lifetime […]
-
The event will bring together leaders from the industry, research, innovation and Governments from more than 70 Countries to address the wide-ranging needs of the healthcare system.
-
Hyderabad: Hyderabad-based Genome Foundation has entered into a Memorandum of Understanding (MoU) with The Federation of Asian Biotech Associations (FABA), Hyderabad, to provide training to students, scientists, clinicians and medical graduates by sharing the available expertise and facilities. The two entities will collaborate to supplement, support and strengthen their sources and provide structured modules of […]
-
“Many people wonder how we’ve done in less than a year what usually takes at least 4-5 years. It is through getting rid of the dead space," said Dr Peter Marks, director of CBER, FDA
-
Vision of growing the industry to over $100 billion by 2030 looks plausible, says KTR